Table 8. Correlation between serum CRP (mg/L) and NFEs.
| Days of measurement | CRP levels (mg/L) | No of patients (%) |
|---|---|---|
| Day 1 of Chemotherapy cycle | Less than 10 (0-35) | 112 (100%) |
| Day 1 of NFEs | More than 40 | 36 (32.1%) |
| Less than 40 | 76 (67.9%) | |
| Day 2 of NFEs | More than 40 | 72 (64.3%) |
| Less than 40 | 40 (35.7%) | |
| Day 3 of NFEs | More than 40 | 79 (70.6%) |
| Less than 40 | 33 (29.5%) | |
| Antimicrobials in NFEs (day 4 of NFEs) | More than 40 | 42 (37.5%) |
| Less than 40 | 70 (67.9%) | |
| Antimicrobials in NFEs (day 7 of NFEs) | More than 40 | 51 (45.6%) |
| 61 (54.5%) |